Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,020.00    -52.00 (-2.51%)
Bid:
2,008.00
Ask:
2,016.00
Spread: 8.00 (0.398%)
Market Cap: £1.34b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Board Update

26 Feb 2009 07:00

RNS Number : 8965N
Genus PLC
26 February 2009
 



For immediate release 26 February 2009

Genus plc 

("Genus" or "the Company")

Board Update

Genus, a world leading animal genetics company, today announces that John Worby has been appointed as Finance Director of the Company with immediate effect. Mr Worby replaces Martin Boden who will be leaving the Company today to pursue other opportunities. John Worby joined the Board of the Company in September 2004 when he also became Chairman of the Audit Committee. Genus intends to strengthen the non executive representation on the Board by recruiting a replacement Audit Committee Chairman and enhancing the international commercial experience of the Board, particularly in emerging markets. A further announcement on this matter will be made in due course.

For further information please contact: Genus plc Tel: 01256 345 970 John Hawkins, Chairman

Buchanan Communications Tel: 020 7466 5000 Charles Ryland Isabel Podda Jennie Spivey About Genus Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain. The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network. Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGGZZNKMGLZM
Date   Source Headline
13th Aug 200910:36 amRNSNotice of Results
31st Jul 20092:00 pmRNSTotal Voting Rights
31st Jul 20092:00 pmRNSBlocklisting Return
15th Jul 20092:00 pmRNSHolding(s) in Company
9th Jul 20097:00 amRNSPre-Close Trading Update
1st Jun 20092:00 pmRNSTotal Voting Rights
20th May 20092:00 pmRNSDirector/PDMR Shareholding
18th May 20092:00 pmRNSDirector/PDMR Shareholding
7th May 20097:00 amRNSBoard Appointment
1st May 20097:00 amRNSInterim Management Statement
30th Apr 20092:00 pmRNSTotal Voting Rights
14th Apr 20092:00 pmRNSHolding(s) in Company
6th Apr 20092:00 pmRNSAppointment of Broker & Adviser
3rd Mar 20092:00 pmRNSDirector's Share Options
26th Feb 20097:00 amRNSBoard Update
26th Feb 20097:00 amRNSInterim Results
20th Feb 20097:00 amRNSBusiness Expansion in China
5th Feb 200910:17 amRNSNotice of Results
30th Jan 20092:30 pmRNSBlocklisting Six Monthly Return
30th Jan 20092:30 pmRNSTotal Voting Rights
5th Jan 20097:00 amRNSAppointment of Brokers & Advisers
31st Dec 200812:40 pmRNSSecond Price Monitoring Extn
31st Dec 200812:37 pmRNSPrice Monitoring Extension
8th Dec 20084:33 pmRNSDirector/PDMR Shareholding
14th Nov 20084:04 pmRNSHolding(s) in Company
13th Nov 20083:06 pmRNSResult of AGM
13th Nov 20087:00 amRNSAGM & Interim Management Statement
27th Oct 20082:00 pmRNSHolding(s) in Company
17th Oct 20082:00 pmRNSAnnual Information Update
15th Oct 20082:30 pmRNSDirector/PDMR Shareholding
15th Oct 20082:00 pmRNSBoard Update
8th Oct 20084:47 pmRNSDirector/PDMR Shareholding
7th Oct 20082:00 pmRNSHolding(s) in Company
30th Sep 20082:08 pmRNSBlocklisting Interim Review
30th Sep 20082:00 pmRNSTotal Voting Rights
19th Sep 20081:37 pmRNSDirector/PDMR Shareholding
18th Sep 20087:00 amRNSUpdate on Strategy - China
16th Sep 20087:00 amRNSPreliminary Results
31st Jul 20084:00 pmRNSTotal Voting Rights
25th Jul 20084:00 pmRNSBlocklisting Interim Review
16th Jul 20087:00 amRNSPre-Close Trading Update
14th Jul 20082:00 pmRNSHolding(s) in Company
30th Jun 20084:30 pmRNSTotal Voting Rights
30th May 20084:00 pmRNSTotal Voting Rights
28th May 200812:06 pmRNSMerger Update
19th May 20083:51 pmRNSDirector/PDMR Shareholding
14th May 20084:00 pmRNSMerger Update
30th Apr 20084:00 pmRNSTotal Voting Rights
29th Apr 20087:00 amRNSInterim Management Statement
10th Apr 20084:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.